Molecular Disease Eradication is a Prerequisite for Long-term Remission in Patients with t(8;21) Positive Acute Myeloid Leukemia: a Single Center Study

References

• Byrd, J.C., Mrozek, K., Dodge, R.K., Carroll, A.J., Edwards, C.G., Arthur, D.C., et al. (2002) "Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)", Blood, 100(13), 4325–4336.
   PubMed Web of Science ®Google Scholar
• Slovak, ML., Kopecky, K.J., Cassileth, P.A., Harrington, D.H., Theil, KS., Mohamed, A., et al. (2000) "Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/ Eastern Cooperative Oncology Group study", Blood, 96(13), 4075–4083.
   PubMed Web of Science ®Google Scholar
• Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., et al. (1998) "The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukemia Working Parties", Blood, 92(7), 2322 — 2333.
   Google Scholar
• Byrd, J.C., Dodge, R.K., Carroll, A., Baer, MR., Edwards, C., Stamberg, J., et al. (1999) "Patients with t(8;2I)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered", J. Clin. Oncol., 17(12), 3767 — 3775.
   Web of Science ®Google Scholar
• Burnett, AK., Goldstone, A.H., Stevens, R.M.F., Hann, TM., Rees, J.K.H., Gray, R.,G., et al. (1998) "Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medial Research Council Adult and Children's Leukaemia Working Parties", Lancet, 351(9104), 700 — 708.
   PubMed Web of Science ®Google Scholar
• Downing, JR., Head, DR., Curcio-Brint, AM., Hulshof, M.G., Motroni, T.A., Raimondi, S.C., et al. (1993) "An AMLI/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;2I)(q22;q22) translocation", Blood, 81(11), 2860— 2865.
   PubMed Web of Science ®Google Scholar
• Mitterbauer, M., Kusec, R., Schwarzinger, I., Haas, O.A., Lechner, K. and Jaeger, U. (1998) "Comparison of karyotype analysis and RT-PCR for AMLI/ETO in 204 unselected patients with AML", Ann. Hematol., 76(3-4), 139 — 143.
   Web of Science ®Google Scholar
• Yin, J.A. and Grimwade, D. (2002) "Minimal residual disease evaluation in acute myeloid leukaemia", Lancet, 360(9327), 160 — 162.
   PubMed Web of Science ®Google Scholar
• Grimwade, D. (2002) "The significance of minimal residual disease in patients with t(15;17)", Best Pract. Res. Clin. Haematol., 15(1), 137 —158.
   Google Scholar
• Laczika, K., Mitterbauer, G., Mitterbauer, M., Knobl, P., Schwarzinger, I., Greinix, H.T., et al. (2001) "Prospective monitor-ing of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYHI 1 RT-PCR: implications for a monitoring schedule and for treatment decisions", Leuk. Lympho-ma, 42(5), 923 — 931.
   PubMed Web of Science ®Google Scholar
• Marcucci, G., Caligiuri, M.A. and Bloomfield, C.D. (1997) "Defining the 'absence' of the CBFbeta/MYHII fusion transcript in patients with acute myeloid leukemia and inversion of chromo-some 16 to predict long-term complete remission: a call for definitions", Blood, 90(12), 5022–5024.
   PubMed Web of Science ®Google Scholar
• Jurlander, J., Caligiuri, MA., Ruutu, T., Baer, MR., Strout, M.P., Oberkircher, A.R., et al. (1996) "Persistence of the AMLI/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia", Blood, 88(6), 2183–2191.
   PubMed Web of Science ®Google Scholar
• Kusec, R., Laczika, K., Knobl, P., Friedl, J., Greinix, H., Kahls, P., et al. (1994) "AML 1 /ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow trans-plantation", Leukemia, 8(5), 735 —739.
   PubMed Web of Science ®Google Scholar
• Maruyama, F., Stass, S.A., Estey, E.H., Cork, A., Hirano, M., Ino, T., et al. (1994) "Detection of AML 1 /ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia", Leukemia, 8(1), 40–45.
   PubMed Web of Science ®Google Scholar
• Miyamoto, T., Nagafuji, K., Akashi, K., Harada, M., Kyo, T., Akashi, T., et al. (1996) "Persistence of multipotent progenitors expressing AML 1 /ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia", Blood, 87(11), 4789 — 4796.
   PubMed Web of Science ®Google Scholar
• Nucifora, G., Larson, R.A. and Rowley, J.D. (1993) "Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission", Blood, 82(3), 712–715.
   PubMed Web of Science ®Google Scholar
• Satake, N., Maseki, N., Kozu, T., Sakashita, A., Kobayashi, H., Sakurai, M., et al. (1995) "Disappearance of AMLI-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;2 I) in long-term remission", Br. J. Haematol., 91(4), 892–898.
   Web of Science ®Google Scholar
• Saunders, Mi., Tobal, K. and Yin, J.A. (1994) "Detection of t(8;21) by reverse transcriptase polymerase chain reaction in patients in remission of acute myeloid leukaemia type M2 after chemotherapy or bone marrow transplantation", Leuk. Res., 18(12), 891 —895.
   Google Scholar
• Fujimaki, S., Funato, T., Harigae, H., Imaizumi, M., Suzuki, H., Kaneko, Y., et al. (2000) "A quantitative reverse transcriptase polymerase chain reaction method for the detection of leukaemic cells with t(8;21) in peripheral blood", Eur. J. Haematol., 64(4), 252— 258.
   PubMed Web of Science ®Google Scholar
• Kondo, M., Kudo, K., Kimura, H., Inaba, J., Kato, K., Kojima, S., et al. (2000) "Real-time quantitative reverse transcription-polymer-ase chain reaction for the detection of AMLI-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia", Leuk. Res., 24(11), 951 — 956.
   Google Scholar
• Krauter, J., Wattjes, M.P., Nagel, S., Heidenreich, O., Krug, U., Kafert, S., et al. (1999) "Real-time RT-PCR for the detection and quantification of AML 1 /MTG8 fusion transcripts in t(8;21)-positive AML patients". Br. J. Haematol., 107(1), 80–85.
   Web of Science ®Google Scholar
• Marcucci, G., Livak, K.J., Bi, W., Strout, M.P., Bloomfield, C.D. and Caligiuri, M.A. (1998) "Detection of minimal residual disease in patients with AMLUETO- associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay", Leukemia, 12(9), 1482— 1489.
   PubMed Web of Science ®Google Scholar
• Tobal, K., Newton, J., Macheta, M., Chang, J., Morgenstern, G., Evans, P.A., et al. (2000) "Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse", Blood, 95(3), 815–819.
   PubMed Web of Science ®Google Scholar
• Elmaagacli, A.H., Beelen, D.W., Stockova, J., Trzensky, S., Kroll, M., Schaefer, U.W., et al. (1997) "Detection of AMLI/ETO fusion transcripts in patients with t(8;21) acute myeloid leukemia after allogeneic bone marrow transplantation or peripheral blood progenitor cell transplantation", Blood, 90(8), 3230— 3231.
   PubMed Web of Science ®Google Scholar
• Morschhauser, F., Cayuela, J.M., Martini, S., Baruchel, A., Rousselot, P., Socie, G., et al. (2000) "Evaluation of minimal residual disease using reverse-transcription polymerase chain reac-tion in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients", J. Clin. Oncol., 18(4), 788–794.
   Web of Science ®Google Scholar
• Sperr, W.R., Piribauer, M., Agis, H., Mitterbauer, M., Geissler, K., Haas, O.A., et al. (2003) "Intermittent intermediate dose ARA-C as consolidation therapy for AML in the elderly", Blood, 90\(Suppl. 1), 509a.
   Google Scholar
• McSweeney, PA., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., et al. (2001) "Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus- tumor effects", Blood, 97(11), 3390 — 3400.
   PubMed Web of Science ®Google Scholar
• Mitelmann, Fe. ISCN (1995) An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: Karger.
   Google Scholar
• Mitterbauer, G., Zimmer, C., Fonatsch, C., Haas, O., Thalhammer-Scherrer, R., Schwarzinger, I., et al. (1999) "Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR", Leukemia, 13(10), 1519–1524.
   PubMed Web of Science ®Google Scholar
• Kwok, S. and Higuchi, R. (1989) "Avoiding false positives with PCR", Nature, 339(6221), 237–238.
   PubMed Web of Science ®Google Scholar
• Mannhalter, C., Koizar, D. and Mitterbauer, G. (2000) "Evaluation of RNA isolation methods and reference genes for RT-PCR analyses of rare target RNA", Clin. Chem. Lab. Med., 38(2), 171— 177.
   Google Scholar
• Asou, H., Tashiro, S., Hamanoto, K., Otsuji, A., Kita, K. and Kamada, M. (1991) "Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with t(8;2I chromosome transloca-tion", Blood, 77(9), 2031–2036.
   PubMed Web of Science ®Google Scholar
• Costello, R., Sainty, D., Blaise, D., Gastaut, JA., Gabert, J., Poirel, H., et al. (1997) "Prognosis value of residual disease monitoring by polymerase chain reaction in patients with CBF beta/MYHI 1-positive acute myeloblastic leukemia", Blood, 89(6), 2222–2223.
   PubMed Web of Science ®Google Scholar
• Pallisgaard, N., Hokland, P., Riishoj, D.C., Pedersen, B. and Jorgensen, P. (1998) "Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia", Blood, 92(2), 574 — 588.
   PubMed Web of Science ®Google Scholar
• Miyamoto, T., Weissman, I.L. and Akashi, K. (2000) "AMLI / ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation", Proc. Natl. Acad. Sci. USA, 97(13), 7521–7526.
   PubMed Web of Science ®Google Scholar